Author response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosis

Neurol Clin Pract. 2018 Jun;8(3):175-176. doi: 10.1212/CPJ.0000000000000470.
No abstract available

Publication types

  • Editorial